Hepatic Disposition of Tilorone Hydrochloride in the Rat
- 1 January 1977
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 7 (6) , 339-344
- https://doi.org/10.3109/00498257709035792
Abstract
1. The hepatic disposition of tilorone HCl, an antiviral and antitumour agent, was studied in male Wistar rats after intraduodenal administration. 2. A concentrative transfer into the liver occurred, the liver/portal blood concentration ratio being 120 or higher. The relationship between dose and hepatic concentration was linear. 3. Biliary excretion of tilorone was low and dose-related; whole blood concentration was also dose-related. 4. Neither hepatic concentration nor biliary excretion exhibited saturation over the dosage studied (6-174 mg/kg). The hepatic ‘depot’ of tilorone lacked the characteristics of a true ‘first-pass’ effect.This publication has 7 references indexed in Scilit:
- Tilorone hydrochloride—A specific probe for A-T regions of duplex deoxyribonucleic acidBiochemical Pharmacology, 1976
- The Anti-inflammatory Actions of Tilorone HydrochlorideExperimental Biology and Medicine, 1975
- Route of Administration and Drug DispositionDrug Metabolism Reviews, 1975
- Bioavailability of DrugsNew England Journal of Medicine, 1974
- Subcellular distribution of14C-tilorone hydrochloride in tissues of mice and ratsThe Science of Nature, 1973
- Tilorone Hydrochloride: Mode of ActionScience, 1970
- Tilorone Hydrochloride: An Orally Active Antiviral AgentScience, 1970